Company

cecava GmbH

Biotechnology Research Tuebingen, Baden-württemberg, De 6 employees CLOSI

Employees: 6
Contacts: 1
Emails: 1

cecava GmbH Overview

Headquarters: Tuebingen, Baden-württemberg, De
Industry: Biotechnology Research
Employees: 6
Founded: 2018
Stock Symbol: CLOSI
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

to the IHK or the Neckar-Alb region through many years of commitment.

About cecava GmbH

cecava GmbH is a biopharmaceutical immuno-oncology company located in Tuebingen (Germany). Founded in 2018, cecava’s mission is to develop individualized peptide cancer therapies (INPECT). The therapy is tailored to target the patient-individual tumor mutations. Through immunizations with the AI-selected neoepitope peptides, the immune system is activated and directed against the patient’s tumor. Based on encouraging real-world experience with this novel immunotherapy, clinical trials are currently being prepared. The company’s ultimate goal is to secure the approval for this innovative treatment, ensuring that as many cancer patients as possible may benefit.

cecava GmbH Contact Details

People in AeroLeads: 4
With contact data: 1
Email contacts: 1; 25.0% coverage

cecava GmbH Org Chart

Sample employees and titles

Name	Title	Location	Contact
Dr. Dirk Hadaschik	Chief Scientific Officer (Cso)	Stuttgart Region, Germany	Email
Eike Pertuch	Bioinformatician at Cecava Gmbh	Tübingen, Baden-württemberg, Germany	View
Evgenia N.	Director of Quality / Individualised	Bisingen, Baden-württemberg, Germany	View
Dr. Martina Knirsch	Director Strategic Partnerships		View